Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 2 与安慰剂平行对照,评价试验药治疗非酒精性脂肪肝安全性 、有效性、随机、双盲单中心临床研究
[Translation] A randomized, double-blind, single-center clinical study to evaluate the safety and efficacy of the experimental drug in the treatment of non-alcoholic fatty liver disease in parallel with a placebo
初步评价丹芍肝康颗粒治疗非酒精性脂肪肝(肝郁脾虚、湿热内蕴证)的安全性及临床有效性
[Translation] Preliminary evaluation of the safety and clinical effectiveness of Danshao Gankang granules in the treatment of non-alcoholic fatty liver disease (liver depression, spleen deficiency, internal dampness and heat syndrome)
100 Clinical Results associated with Shanghai Huazhi Natural Medicine Technology Development Co., Ltd.
0 Patents (Medical) associated with Shanghai Huazhi Natural Medicine Technology Development Co., Ltd.
100 Deals associated with Shanghai Huazhi Natural Medicine Technology Development Co., Ltd.
100 Translational Medicine associated with Shanghai Huazhi Natural Medicine Technology Development Co., Ltd.